Name: Retatrutide Research Peptide
Brand: RetaLABS
SKU: retatrutide
Availability: InStock
Rating: 4.8 (20 reviews)

Question 1

What is reta peptide?

Accepted Answer

"Reta" is the shorthand researchers commonly use for retatrutide (Eli Lilly's LY3437943), a triple receptor agonist that activates the GLP-1, GIP and glucagon receptors simultaneously. Supplied as a lyophilised research-grade peptide, reta is studied for its effects on energy expenditure, appetite signalling and insulin sensitivity in receptor-pharmacology and metabolic-disease models. In published Phase 2 work (NEJM, 2023) the compound produced the largest mean weight reductions reported in its class, and the Phase 3 TRIUMPH programme is ongoing in 2026. RetaLABS stocks research-grade reta peptide in 10mg, 20mg and 30mg lyophilised vials for laboratory research use only, each batch HPLC purity-tested with a batch-specific Certificate of Analysis available on request. The terms "reta", "reta peptide" and "retatrutide" refer to the same compound — interchangeable shorthand used within the research community.

Question 2

Where can researchers buy reta peptide in Australia?

Accepted Answer

Research-grade reta (retatrutide) is supplied to Australian laboratories under the research-use-only framework rather than through retail pharmacies, because therapeutic registration sits on a separate regulatory pathway from research-compound supply. RetaLABS dispatches reta peptide Australia-wide via Australia Post Express — tracked, with no separate shipping charge — typically within 1–2 business days of confirmed payment, and accepts cryptocurrency (BTC, LTC, XMR) at no surcharge. Reta is stocked in 10mg, 20mg and 30mg lyophilised vials; each batch is HPLC purity-tested with a batch-specific Certificate of Analysis available on request, and AUD pricing is shown above the fold with volume tiers applied automatically at the cart. Buyers attest at checkout that the compound is acquired solely for laboratory research applications.

Question 3

Is Retatrutide available in Australia?

Accepted Answer

Research-grade Retatrutide is supplied to Australian laboratories under the research-use-only framework, which is the established supply pathway for early-stage compounds not registered for therapeutic use. Eli Lilly's LY3437943 — the triple-receptor agonist studied across the TRIUMPH Phase 3 programme — is available in Australia as a lyophilised research peptide through dedicated research-grade suppliers, not via retail pharmacies, because human therapeutic registration sits in a separate regulatory pathway from research-compound supply. RetaLABS dispatches research-grade Retatrutide Australia-wide via Australia Post Express, typically within 1–2 business days of confirmed payment. Each vial contains research-purity lyophilised peptide intended for in-vitro and preclinical work in receptor pharmacology, metabolic-disease modelling, and dose-response research. Buyers attest at checkout that the compound is acquired solely for research applications. Researchers requiring supplementary documentation should reference the published Phase 2 and Phase 3 protocols when designing their own studies. The Australian research framework is detailed in our research peptides legal status guide.

Question 4

Where can I buy research-grade Retatrutide in Australia?

Accepted Answer

RetaLABS supplies research-grade Retatrutide to Australian researchers in 10mg, 20mg and 30mg lyophilised vials for laboratory research use only. Orders are dispatched Australia-wide by Australia Post Express — tracked, with no separate shipping charge — and cryptocurrency payment is accepted at no surcharge. Each batch is HPLC purity-tested, with a batch-specific Certificate of Analysis available on request. Current AUD pricing for each vial size is shown on the product page, and volume pricing is applied automatically at the cart on multi-vial orders.

Question 5

How should Retatrutide be stored?

Accepted Answer

Lyophilised Retatrutide should be stored at −20°C for long-term stability, protected from light and repeated temperature fluctuations. The lyophilised powder form is the most stable format — freeze-drying removes water, which is the primary driver of peptide degradation — and will remain stable for extended periods at −20°C when the vial seal is intact. Once reconstituted with bacteriostatic water, the resulting solution should be refrigerated at 2–8°C and used within four weeks. Reconstituted solutions are susceptible to aggregation and microbial contamination over time, so researchers should minimise the interval between reconstitution and use where protocol allows. Avoid repeated freeze-thaw cycles on reconstituted solution, as thermal cycling can cause peptide degradation and aggregation. For protocols spanning multiple weeks, consider aliquoting the reconstituted solution into single-use volumes stored at −20°C, then thawing only what is needed per session.

Question 6

What does research-grade Retatrutide cost in Australia?

Accepted Answer

Research-grade Retatrutide pricing in Australia depends on vial dosage, supplier purity standards, batch documentation, and order quantity. RetaLABS lists research-grade Retatrutide in 10mg, 20mg and 30mg lyophilised peptide vials, with current AUD pricing displayed above the fold on each product page and volume-pricing tiers automatically applied at the cart on multi-vial orders. The 20mg vial corresponds to the reference dose configuration used across most published Phase 2 protocols, including the NEJM 2023 retatrutide trial, which makes it the typical first-order configuration for researchers replicating dose-response studies. The 30mg vial suits longer or higher-dose research timelines where consolidating storage reduces freeze-thaw exposure across the protocol period. All AUD prices listed include Australia Post Express tracked dispatch nationwide — there is no separate shipping charge added at checkout, and crypto payment options carry no surcharge. Researchers comparing cost-per-milligram across Australian suppliers should verify research-grade purity standards and dispatch origin alongside headline pricing.

Question 7

What reconstitution method is recommended?

Accepted Answer

Bacteriostatic water is the recommended diluent for reconstituting Retatrutide in most research applications. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which inhibits microbial growth and allows multi-use withdrawal from the reconstituted vial across days or weeks of research. To reconstitute, draw the required volume of bacteriostatic water into a syringe and inject it slowly along the inner glass wall of the peptide vial — do not inject directly onto the lyophilised powder. Gently swirl the vial in a circular motion until the powder is fully dissolved; do not shake vigorously, as mechanical shaking can cause peptide aggregation. Allow the vial to rest for several minutes if the powder is slow to dissolve. Typical research concentrations range from 2–5 mg/mL depending on protocol requirements. Once reconstituted, store at 2–8°C and use within four weeks. Label the vial with the reconstitution date.

Vial	Price (AUD)	Per mg	Availability
10mg	A$115.00	A$11.50/mg	In stock
20mg	A$160.00	A$8.00/mg	In stock
30mg	A$210.00	A$7.00/mgbest value	In stock

Reta (Retatrutide) Research Peptides — Buy Online Australia

Retatrutide Research

Retatrutide 20mg

Retatrutide 30mg

Retatrutide 10mg

Compare GLP-1 Peptides

Product Specifications

Frequently Asked Questions

Research Guides